Genetic variants related to successful migraine prophylaxis with verapamil

BACKGROUND: Currently, there is no biologically based rationale for drug selection in migraine prophylactic treatment. METHODS: To investigate the genetic variation underlying treatment response to verapamil prophylaxis, we selected 225 patients from a longitudinally established, deeply phenotyped m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutrer, Fred Michael, Moyer, Ann M., Atkinson, Elizabeth J., Wang, Liguo, Tian, Shulan, Wu, Yanhong, Garza, Ivan, Robertson, Carrie E., Huebert, Carey A., Moore, Brenda E., Klein, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222836/
https://www.ncbi.nlm.nih.gov/pubmed/33829662
http://dx.doi.org/10.1002/mgg3.1680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222836/
https://www.ncbi.nlm.nih.gov/pubmed/33829662
http://dx.doi.org/10.1002/mgg3.1680

Ejemplares similares